Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherap. LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 16.75p 20,368 08:00:00
Bid Price Offer Price High Price Low Price Open Price
16.50p 17.00p 16.75p 16.75p 16.75p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -0.94 -0.71 19.9

Skinbiotherap. (SBTX) Latest News

More Skinbiotherap. News
Skinbiotherap. Takeover Rumours

Skinbiotherap. (SBTX) Share Charts

1 Year Skinbiotherap. Chart

1 Year Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Skinbiotherap. (SBTX) Discussions and Chat

Skinbiotherap. (SBTX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
09:42:1916.794,000671.60O
09:37:1816.794,500755.55O
09:29:2916.7511,8681,987.89O
View all Skinbiotherap. trades in real-time

Skinbiotherap. (SBTX) Top Chat Posts

DateSubject
20/3/2019
08:20
Skinbiotherap. Daily Update: Skinbiotherap. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherap. was 16.75p.
Skinbiotherap. has a 4 week average price of 16.50p and a 12 week average price of 12.25p.
The 1 year high share price is 29.50p while the 1 year low share price is currently 8.25p.
There are currently 118,708,494 shares in issue and the average daily traded volume is 61,396 shares. The market capitalisation of Skinbiotherap. is £19,883,672.75.
08/3/2019
07:45
jamesrs1: Mr Chung. Its an Ideal opportunity for you to buy more then. Ready for when the share price goes up.
28/1/2019
11:01
best1467: I would suggest looking back through the data this longer test is designed to prove if the treatment does increase moisture levels in the skin something that as of yet we can not be 100% sure it does and at what percentage the greater the better. Time will tell but if we get really high moisture levels back I would expect a major rise in the share price .
25/1/2019
12:26
incanus: With respect, we have already been told the key milestones have already been passed. The last study is only expect to confirm what the company already knows. The share price are at these levels for a number of reasons. Most investors thought the trials where expect to last no longer than october and with data produced in november. Sbtx change this in favour of a far more detailed study than originally thought. This should have demonstrated confidence in the tech. Then just as we are recovering after the realisation the study is going to take us right through to april and the shock of this, there was the eventual realisation this was a good thing and thus the shares rallied to another attempt at breaking the all time high of 30p. All was looking fine until some broker called turner and pope phoned some of their clients asking if they wanted Sbtx stock at 19p when the share price was 29p. This of course killed all momentum and confidence. This has never been explained to investors like me. I sold alot of my shares on the leak placing news and only now have i decided to buy them back.
21/1/2019
22:23
jamesrs1: Pretax2. This is nothing like a busted bubble. More interest shown in buying today than over the last few weeks. If you’re expecting an immediate 10p rise in share price I suggest you look elsewhere. The closer to news at the end of Q1 will bring more buyers. Surely you wouldn’t be happy to sit on your investment for gains in line with inflation. Sounds to me like you’re trying to run it down and buy at a cheaper price. To transparent mate.
21/8/2018
23:01
ktfkoko: Wrong again, paranoia . What's your obsession with this Rayrac person , I'm not him I'm a her , and that's some insecurity you have . To be honest I am deleting my account as I told advfn there are too many rude arrogant people on this message board. Self Opinionated too. I will repeat , I liked the potential product , but the way the presentation was carried out made the share price drop like a stone , because she did not THINK about the impact of the way she presented the possible instability of the cream ( even though it wasn't the end product ) was going to have on the share price . She should get professional help with presentations . End of .
16/8/2018
13:58
mshilos: SBTX going below 20 p today and lower in the comings for reasons I explained in an earlier post below. In addition OPTI is now below £1 ...reason is as below : There is HUGE positive sentiment for OPTI and share price has soared recently on the back of this , but nothing more, no profit no HUGE contracts to report, no major news, etc, and NO PROFITS to report. They do have MASSIVE potential, if their LT plans are executed according to plan and they do have a great Founder/CEO. However, as a LT holder myself, since 27p I would expect the share price to fall to the 50-60 p levels before 2019 BUT to climb to over £2 in the next 2 years , if we keep moving in the right direction. It is only sentiment that is driven this share price at present, not profit, as there is no profit.IMO DYOR.
16/8/2018
12:06
mshilos: John in reply : I stand by my opinion that the clinical trial will now have to be delayed and there will need to be an RNS to confirm this once they know when it will take place. The share price will fall to the initial April 2017 price or lower until we have trial results. This is still in its infancy and far far away from a profit generating business but the potential is huge hence the recent share price price rise based on sentiment and potential alone. This RNS is not good news...it will drop more ...IMO. DYOR.
02/8/2018
11:43
rafboy: Certainly think there is a company or two keeping a very close eye on SBTX. In 6 months the share price is likely to be 2 or 3 times the current share price assuming the human skin trials are a success. However, we have anecdotal evidence showing that the team at SBTX are currently using the cream. We also know it has been tested on human skin in the lab. I believe the likelihood is that the human skin trials will be a success and that a deal will follow on fairly quickly. Just my personal view.
28/7/2018
16:00
speccy1: The more I think about it, the more sense it makes to place the OPTI held shares with an institutional investor and pay a cash divi. If the sale includes a lock-in period, it not only safeguards the SBTX share price, but given many of the OPTI investors would use their divi to buy SBTX, it could significantly improve the share price. The problem could then be everyone fighting to spend their divi at once and a mass charge causing a short term spike. It would be a terrible dilemma whether to buy straight away or hang fire until the initial rush for shares has died down. First World problems :)
21/4/2018
20:46
onedayrodders: I posted this on OPTI board but will be of interest here .. Hey all, myself and Trotters were at the UK Investor show today and were chatting with SOH for quite a while.. I'm sure Trotters will be posting a few nuggets later but I know the SBTX divi is an Important issue many have asked about so here is what he said. They are absolutely aware and focused on making this as fair as possible by not allowing short term traders to benefit or damage either OPTI or SBTX share price. Options being discussed ... 1. Lock in period - Unlikely as regulators do not like this type of arrangement and view it as restricting the market. 2. Staggered benefit, for example, OPTI will give shareholders say 1000 SBTX shares and promise another 1000 shares the next year providing the first 1000 shares have not been sold. 3. Take advantage of increasing interest in Skinbiotix by selling a % of OPTI's stake in SBTX to by Institutional investors and delivering a SBTX cash divi. (Therefore delivering the SBTX divi promise, adding long term Institutional shareholders and removing volatility in the share price - my take) The qualifying for any divi, either shares or cash will be controlled by a record date and that cannot be a date in the past and will be from close of business on the day the divi details are announced. So they will be looking to time that towards the end of the day to allow the smallest window possible for the AIM trading vultures (my words not his !) That's from memory so hope I got it right (Trotters..correct me if I'm wrong) ODR
Skinbiotherap. share price data is direct from the London Stock Exchange
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190320 16:39:32